Compare Novo Nordisk A/S (NVO) vs Reddit Inc (RDDT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs Reddit Inc — how do they compare? Novo Nordisk A/S trades at $38.64 (market cap $165.31B), while Reddit Inc trades at $159.84 (market cap $30.10B). The key difference: Novo Nordisk A/S is far larger — about 5.5× Reddit Inc's market cap, and Novo Nordisk A/S pays a 4.71% dividend while Reddit Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Novo Nordisk A/S for 116 Days and Reddit Inc for 26 Days on average.
| NVO | RDDT | |
|---|---|---|
Market Cap | $165.31B | $30.10B |
Volume | 11,432,838 | 4,560,440 |
Sector | Health | Media |
52-Week High | $63.98 | $258.93 |
52-Week Low | $35.29 | $121.84 |
Typical Hold Time | 116 Days | 26 Days |
Enterprise Value | $179.56B | $27.34B |
Dividend Yield | 4.71% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Novo Nordisk (NVO) trades at $38.18, down 0.21% with a bearish technical signal. The stock shows strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and robust profitability (35.35% net margin, 59.82% ROE). Recent news highlights pipeline developments including Wegovy pill data and a $4 billion licensing deal, though the FDA extended review of its hemophilia drug. Cash flow remains positive at $10.81B for 2025, supporting dividend payments.
NVO presents a compelling value opportunity with a 9.66 P/E ratio and 17% upside to the $44.67 consensus target. However, competitive pressure from Eli Lilly's obesity drug pipeline and regulatory delays pose near-term risks. Analyst sentiment is bullish (59% buy ratings), but investors should monitor Q3 2026 earnings against the 0.753 EPS expectation for confirmation of growth trajectory.
Reddit (RDDT) trades at $156.49, up 2.44% today, showing strong momentum after recent earnings beats. The stock maintains a bullish technical outlook with support at $154 and resistance at $158. Fundamentally, the company demonstrates exceptional profitability with 91.44% gross margins and 31.35% net income margins, though valuation metrics remain elevated with a P/E of 36.39. Recent news highlights strategic partnerships and international expansion driving growth.
Outlook remains positive with analyst consensus at $202.52 (29% upside) and 65% buy ratings. Key opportunities include AI data licensing growth and international monetization, while risks involve competitive pressures and potential valuation compression given premium multiples. The company's transition to profitability and strong cash flow generation support continued expansion.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About Reddit Inc
Reddit Inc. operates a vast network of online communities organized around various interests, known as 'subreddits'. Functioning as a hybrid of a social media platform and a discussion forum, the company generates revenue primarily through advertising and premium subscriptions. Reddit is a major hub for user-generated content, trending news, and viral discussions, and it is a key player in the digital advertising and social media landscape.
Read more on RDDT →
